Clinical Trial Update: Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the efficacy and safety of rabbit antithymocyte globulin (Thymoglobulin) at 3 mg/kg in kidney transplant patients managed with a steroi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Hospital Geral de Fortaleza | Conditions: Thymoglobulin Dose | Phase 4 | Status: UNKNOWN